UNIPHARM, INC. is a leading American pharmaceutical company specializing in the marketing and development of nutritional supplements and over-the-counter (OTC) drugs. Unipharm, Inc. was established in 1992 and incorporated in Maryland.

Our products include the VITRUM^® - line of vitamin and mineral supplements, and a wide selection of over-the-counter drug formulas, available only in pharmacies. The uniqueness and high quality of VITRUM^®, products have established VITRUM^® as a well recognized brand name in Russia, Ukraine, Poland, Kazakhstan and other CIS countries.

Most products have been registered as drugs in each country, assayed and verified by the Ministry of Health, Drug Institutes, or other locally designated authorities. Our products are constantly monitored for highest quality.

Our world headquarters are located in the Empire State Building in New York City, with nine branches world-wide. We have over 200 highly trained, innovative and motivated staff people.

Our products are fully competitive, both in terms of quality and price, and comparable to preparations from companies that have been in the pharmaceutical market for decades. We are already number one in the sales of vitamin and mineral preparations in Russia, number one in Ukraine, and our market share is significantly increasing in other CIS countries. Our preparations have already been registered and are available in China, Vietnam and Indonesia.

Unipharm, Inc. history
UNIPHARM, INC., founded in 1992, is a privately owned company incorporated in the State of Maryland (USA), with branches and daughter companies worldwide.

In 1993, with the rapid growth in the international market, the company expanded its activities to offer dietary supplements in solid dosage form (as tablets, capsules and powders). Unipharm, Inc. has a varied and expanding product line packaged (in blister and bottle form) and specifically labeled for top performance in diverse international markets. The company is committed to offer a wide variety of products that can be clinically proven safe and effective. Our capabilities are being constantly upgraded to meet growing market demand.